Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC
Apply
CD40L-Augmented TIL
Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step